Andrew Komjathy SEC EDGAR Filings (CIK 0001788465)

SEC EDGAR filings, ownership reports, and insider transactions for Andrew Komjathy.

Business address
Catabasis Pharmaceuticals, Inc., One Kendall Square, Suite B14202, Cambridge, MA, 02139
Get insider transactions for this reporting owner
Andrew Komjathy has filed 11 SEC EDGAR filings since 19 Sep 2019

Latest Filings

Recent SEC filings for Andrew Komjathy including 4, 5, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 23 Jan 2026 23 Jan 2026 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 25 Mar 2025 21 Mar 2025 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 12 Feb 2024 08 Feb 2024 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 06 Jun 2023 02 Jun 2023 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 03 Mar 2022 01 Mar 2022 001-37467
5 Open 5 document View SEC filing for 5 OWNERSHIP DOCUMENT 10 Feb 2022 28 Dec 2021 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 23 Nov 2021 19 Nov 2021 001-37467
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Jun 2021 02 Jun 2021 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 14 Feb 2020 12 Feb 2020 001-37467
4 Open 4 document View SEC filing for 4 FORM 4 - 19 Sep 2019 18 Sep 2019 001-37467
3 Open 3 document View SEC filing for 3 FORM 3 - 19 Sep 2019 18 Sep 2019 001-37467

About this filer

Andrew Komjathy files with the SEC under CIK 0001788465. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages